Regulus Therapeutics Inc (NASDAQ:RGLS)

18.05
BATS BZX Real-Time Price
As of 10:02am ET
 +0.87 / +5.06%
Today’s Change
5.40
Today|||52-Week Range
25.60
+12.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-12.44%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-18.69%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-2.72%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-2.72%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+24.95%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+24.95%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-7.53%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201523,616$20.81$491.4K-18.69%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201526,227$18.40$482.6K-7.53%
Carter Bruce Leonard Andrews
Director
Sale4/13/201520,000$17.66$353.2K-2.44%
Page of 19

To view my watchlist

Not a member yet?

Sign up now for a free account